Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034
Completed
GlaxoSmithKline
Phase 1
2005-09-26
This study is an exploratory study to evaluate the effectiveness, safety and tolerability of
three concentrations of GW786034 ointment following treatment to small areas of stable
psoriatic plaques. Dosing will proceed using a microplaque approach, where small volumes of
ointment will be applied under full occlusion to representative psoriatic plaques. The
effectiveness of topical GW786034 treatments and controls will be explored using visual
intensity assessments in addition to dermal imaging and histological surrogates of disease
activity.
Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser
Completed
ACO Hud Nordic AB
Phase 3
2004-01-01
Topical steroid creams as well as moisturizing creams are important parts of the treatment
strategy of atopic eczema. This study aims to investigate the tolerance of a new strong
steroid cream in comparison to an already marketed reference cream with equal amount of
active but with different cream vehicle. The second part of the study will investigate the
possible preventative property of a moisturizing cream on skin that has been previously
cleared from eczema.
A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema
Completed
Smerud Medical Research International AS
Phase 4
2007-10-01
The purpose of this study is to investigate whether a moisturizing cream can prevent hand
eczema.Patients with previous hand eczema will be studied. In the second part of the study,
it will be explored if a treatment regimen of a topical corticosteroid once daily is not
inferior to treatment twice daily.
A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema
Completed
ACO Hud Nordic AB
Phase 4
2007-10-01
The purpose of this study is to investigate whether a moisturizing cream can prevent hand
eczema.Patients with previous hand eczema will be studied. In the second part of the study,
it will be explored if a treatment regimen of a topical corticosteroid once daily is not
inferior to treatment twice daily.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
